Sort
11,323 grants matching “glioblastoma”
Irreversible electroporation for combinatorial GBM treatment
$265,953Rafael Vidal Davalos · Wake Forest University Health Sciences · P01 · FY2017 · CA
Biospecimen Acquisition, Processing, and Classification Unit
$265,733Ryan C Fields · Washington University · U2C · FY2022 · CA
Nanostructured Matrices for Cancer Cell Biology
$265,557Milan Mrksich · Northwestern University At Chicago · U54 · FY2014 · CA
Microenvironment determinants of radio-sensitivity in human high grade glioma
$265,528Christopher Paul Cifarelli · West Virginia University · P20 · FY2020 · GM
Targeting the alpha secretase ADAM10 for the treatment of Alzheimer's disease
$265,500Dimitar B Nikolov · Sloan-Kettering Inst Can Research · R21 · FY2023 · AG
Profiling and targeting micro-RNA expression during oncolytic virotherapy
$265,500Hiroaki Wakimoto · Massachusetts General Hospital · R21 · FY2009 · NS
Role of LAP positive immune cells in glioblastoma pathogenesis
$265,438Howard L Weiner · Brigham And Women'S Hospital · R21 · FY2014 · NS
Perivascular Invasion of GBMs
$265,424Gabriele Bergers · University Of California, San Francisco · R01 · FY2007 · CA
Deciphering synergistic combinatorial targets in glioma
$265,423W K Alfred Yung · University Of Tx Md Anderson Can Ctr · R01 · FY2008 · CA
Deciphering synergistic combinatorial targets in glioma
$265,423W K Alfred Yung · University Of Tx Md Anderson Can Ctr · R01 · FY2010 · CA
Deciphering synergistic combinatorial targets in glioma
$265,423W K Alfred Yung · University Of Tx Md Anderson Can Ctr · R01 · FY2009 · CA
Deciphering synergistic combinatorial targets in glioma
$265,423W K Alfred Yung · University Of Tx Md Anderson Can Ctr · R01 · FY2007 · CA
Therapy Evaluation Core
$265,248Jann N Sarkaria · Mayo Clinic Rochester · U19 · FY2025 · CA
MOLECULAR AND FUNCTIONAL ANALYSIS OF HUMAN FGF 1
$265,156Ohio State University · R01 · FY2000 · CA
Project 1: Modeling the Interface between Non-invasive Imaging and Drug Distribution
$264,879Kristin R Swanson · Massachusetts Institute Of Technology · U54 · FY2020 · CA
Vascular Maintenance and Brain Tumor Refractory
$264,875P Charles Lin · Vanderbilt University · R01 · FY2007 · NS
Vascular Maintenance and Brain Tumor Refractory
$264,875P Charles Lin · Vanderbilt University · R01 · FY2008 · NS
TARGETING THE G2/M CHECKPOINT IN GLIOBLASTOMA WITH A COMBINED LOSS OF TP53 AND CDKN2A
$264,750Dana-Farber Cancer Institute, Inc. · · FY2019 · Department of the Army
Identification of Glucose Transporter 3 Inhibitors for Glioblastoma Treatment
$264,677Anita Borton Hjelmeland · University Of Alabama At Birmingham · R21 · FY2016 · NS
FAK and Pky2 in Determination of Glioblastoma Phenotype
$264,504Joseph C Loftus · Mayo Clinic Arizona · R01 · FY2008 · CA
Biospecimen Acquisition, Processing, and Classification Unit
$264,423Ryan C Fields · Washington University · U2C · FY2019 · CA
6-thio-2'-deoxyguanosine in GBM: Evaluation of Pharmaco-dynamics, Effects of Prior Standard of Care and A Human Phase 0 Study
$264,339Mustafa Khasraw · Duke University · U19 · FY2025 · CA
Leveraging doxorubicin immune-modulation, blood-brain barrier opening, and personalized medicine for effective immunotherapy in glioblastoma. A mechanistic approach and pharmacokinetic trial.
$264,248Adam M Sonabend · University Of California, San Francisco · U19 · FY2023 · CA
Leveraging doxorubicin immune-modulation, blood-brain barrier opening, and personalized medicine for effective immunotherapy in glioblastoma. A mechanistic approach and pharmacokinetic trial.
$264,245Adam M Sonabend · University Of California, San Francisco · U19 · FY2022 · CA
SPORE: Targeted Therapies for Glioma - Diversity Supplement
$264,010Tracy T Batchelor · Brigham And Women'S Hospital · P50 · FY2020 · CA